Medicare Enrolled

Dr. Jordan Eisenstock, M.D.

Neurology · Worcester, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
55 LAKE AVE N, Worcester, MA 01655
5083342527
In practice since 2007 (19 years)
NPI: 1164573283 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eisenstock from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eisenstock? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eisenstock

Dr. Jordan Eisenstock is a neurology specialist in Worcester, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Eisenstock performed 1,386 Medicare services across 842 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eisenstock received a total of $7,734 from 53 pharmaceutical and/or device companies across 464 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eisenstock is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in MA $7,734 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,386
Medicare services
Top 11% in MA for neurology
842
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,026 $94 $392
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
200 $138 $537
New patient office visit, complex (60-74 min) 125 $161 $662
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
35 $130 $500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,734
Total received (2018-2024)
Avg $1,105/year across 7 years
Top 28% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
464
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,568 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$166 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$459
2023
$756
2022
$614
2021
$540
2020
$832
2019
$2,127
2018
$2,407

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$235
Lilly USA, LLC
$63
Eisai Inc.
$50
PFIZER INC.
$31
Amneal Pharmaceuticals LLC
$29
Otsuka America Pharmaceutical, Inc.
$28
SCILEX PHARMACEUTICALS INC.
$24
Top 3 companies account for 75.7% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$1,078
ABBVIE INC.
$828
Teva Pharmaceuticals USA, Inc.
$706
Allergan Inc.
$363
AbbVie Inc.
$323
UCB, Inc.
$291
Amneal Pharmaceuticals LLC
$287
Amgen Inc.
$275
Biohaven Pharmaceutical Holding Company Ltd.
$212
Avanir Pharmaceuticals, Inc.
$196
Acorda Therapeutics, Inc
$186
PFIZER INC.
$185
GENZYME CORPORATION
$184
Eisai Inc.
$183
Sunovion Pharmaceuticals Inc.
$178
US WorldMeds, LLC
$168
Allergan, Inc.
$159
Novartis Pharmaceuticals Corporation
$151
Adamas Pharmaceuticals, Inc.
$128
Lundbeck LLC
$124
Vanda Pharmaceuticals Inc.
$119
Impax Laboratories, Inc.
$118
Lilly USA, LLC
$114
Neurocrine Biosciences, Inc.
$111
AbbVie, Inc.
$80
Promius Pharma LLC
$71
Biogen, Inc.
$64
Biohaven Pharmaceuticals, Inc.
$62
EISAI INC.
$61
EMD Serono, Inc.
$59
Shire North American Group Inc
$50
Celgene Corporation
$48
E.R. Squibb & Sons, L.L.C.
$45
Medtronic USA, Inc.
$45
Alnylam Pharmaceuticals Inc.
$39
Upsher-Smith Laboratories LLC
$37
Merz North America, Inc.
$36
GE Healthcare
$35
Takeda Pharmaceuticals U.S.A., Inc.
$30
Merz Pharmaceuticals, LLC
$28
Otsuka America Pharmaceutical, Inc.
$28
GE HealthCare
$27
Greenwich Biosciences, Inc.
$25
ARBOR PHARMACEUTICALS, INC.
$24
SCILEX PHARMACEUTICALS INC.
$24
ACADIA Pharmaceuticals Inc
$23
LivaNova USA, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
ASSERTIO THERAPEUTICS, Inc.
$19
Genentech USA, Inc.
$17
Mitsubishi Tanabe Pharma America, Inc.
$17
Avion Pharmaceuticals
$17
Janssen Pharmaceuticals, Inc
$15
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRINTELLIX · Briviact · COMIRNATY · COPAXONE · Cambia · DUOPA · Dhivy · Duopa · Dysport · EMGALITY · Epidiolex · Fycompa · GOCOVRI · Hetlioz · Horizant · INBRIJA · INGREZZA · KISUNLA · KYNMOBI · LEMTRADA · Leqembi · MYOBLOC · NAMZARIC · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · PAXLOVID · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · SPINRAZA · SPRAVATO · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · VNS Therapy · VRAYLAR · VYVANSE · Vimpat · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Worcester?
Compare neurologists in the Worcester area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Eisenstock is a clinical cardiology specialist, with above-average Medicare volume (top 11% in MA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Eisenstock experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Eisenstock performed 1,026 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eisenstock receive payments from pharmaceutical companies?
Yes. Dr. Eisenstock received a total of $7,734 from 53 companies across 464 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eisenstock's costs compare to other neurologists in Worcester?
Dr. Eisenstock's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eisenstock) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →